Communication Disorders: Clinical Trials

36 trials for Communication Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed. 36 Phase 2, 8 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 236Completed 36
Phase 18Completed 8
Phase 32Completed 2

Follow Communication Disorders: new trials by email Literature Review of Communication Disorders trials Research Report on Communication Disorders

Trials (filtered) newest first · largest first

All 36 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders
Zinc Acetate Dihydrate - GNAO1, Dystonia
Phase 2CompletedChildren's University Hospital Cologne, Germany132024-08-022026-02-03
The Effect of Prior Learning on Word Learning
VAULT Phase 4 - Language Development Disorders
Phase 2CompletedUniversity of Arizona222023-06-012025-06-27
Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)
Transcranial Direct Current Stimulation (tDCS), Word-Naming Activity - Primary Progressive Aphasia
Phase 2CompletedNYU Langone Health112022-12-242024-09-19
A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)
NOE-105, Placebo - Childhood-Onset Fluency Disorder
Phase 2CompletedNoema Pharma AG752022-07-252026-02-20
Visual Acoustic Biofeedback for RSE Via Telepractice
Visual-Acoustic Biofeedback Treatment, No Treatment - Speech Sound Disorder
Phase 2CompletedMontclair State University402022-01-152026-02-17
Dopaminergic Therapy for Frontotemporal Dementia Patients
Rotigotine 4Mg/24Hrs Patch, Rotigotine 6Mg/24Hrs Patch, Placebo - Frontotemporal Dementia, Dementia
Phase 2CompletedI.R.C.C.S. Fondazione Santa Lucia752021-06-032024-10-22
Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)
Ecopipam, Placebo - Childhood-Onset Fluency Disorder (Stuttering)
Phase 2CompletedEmalex Biosciences Inc.682020-10-222026-09-23
Speech Entrainment for Aphasia Recovery
SET (Speech Entrainment Therapy) 3 weeks, SET (Speech Entrainment Therapy) 4.5 weeks, SET (Speech Entrainment Therapy) 6 weeks - Aphasia, Aphasia Non Fluent
Phase 2CompletedMedical University of South Carolina802020-08-212025-11-14
Treating Primary Progressive Aphasia (PPA) Using High-definition tDCS
high-definition transcranial direct current stimulation, modified constraint-induced language therapy - Primary Progressive Aphasia
Phase 2CompletedUniversity of Pennsylvania762020-08-172026-10-19
Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders
Bioactive Factors, Produced by M2 Type Macrophages (M2-BFs). - Language Delay, Language; Developmental Disorder, Expressive
Phase 1 / Phase 2CompletedRussian Academy of Medical Sciences142020-02-012022-05-02
Maximizing Outcomes for Preschoolers With Developmental Language Disorders
the Enhanced Milieu Teaching-Sentence Focus - Developmental Language Disorder
Phase 2CompletedNorthwestern University1082019-04-042026-08-19
Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia
Active TMS, Sham TMS, CILT - Aphasia
Phase 2CompletedH. Branch Coslett862019-03-282025-10-14
PCT for Speech, Language, and Cognitive Intervention in Stroke Patients
PCT, Workbooks - Aphasia, Acquired
Phase 2CompletedThe Learning Corp362019-03-182020-07-27
A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
BPN14770, Placebo - Fragile X Syndrome, FXS
Phase 2CompletedTetra Discovery Partners302018-07-092024-12-19
Building Sentences With Preschoolers Who Use AAC
AAC Generative Language Intervention, Standard of Care / Business as Usual - Down Syndrome, Speech and Language Disorder
Phase 2CompletedUniversity of Central Florida702018-05-112024-01-08
Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study
HD-tDCS (Soterix Medical, Active), HD-tDCS (Soterix Medical, Sham) - Chronic Aphasia
Phase 2CompletedSoterix Medical582015-07-012023-12-05
Brief Behavioral Treatment for Anxiety in Young Children
Parent-Led Exposure Therapy, Treatment As Usual - Obsessive-compulsive Disorder, Social Phobia
Phase 1 / Phase 2CompletedUniversity of South Florida582014-01-012016-10-06
Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
Fluoxetine - Selective Mutism, Social Anxiety
Phase 2CompletedMichigan State University62014-01-012022-05-18
Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer
pre, during and pos-treatment swallowing exercises - Head Neck Cancer, Swallowing Disorders
Phase 2CompletedBarretos Cancer Hospital942012-07-012017-06-28
Brain Stimulation and Aphasia Treatment
Activa Dose II Real tDCS, Activa Dose II Sham tDCS - Aphasia
Phase 2CompletedUniversity of South Carolina742012-04-012019-08-20

Showing 20 of 36. Sign in to see all of them.

Narrower conditions

Aphasia (11)  ·  Learning Disabilities (7)  ·  Stroke (7)  ·  Language (4)  ·  Language Development Disorders (4)  ·  Language Disorders (4)  ·  Aphasia, Primary Progressive (3)  ·  Attention Deficit Disorder with Hyperactivity (3)  ·  Central Nervous System Diseases (3)  ·  Developmental Disabilities (3)  ·  Mental Disorders (3)  ·  Mutism (3)  ·  Aphasia, Broca (2)  ·  Autism Spectrum Disorder (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (34)  ·  Signs and Symptoms (34)  ·  Neurobehavioral Manifestations (33)  ·  Neurologic Manifestations (33)  ·  Nervous System Diseases (32)  ·  Language Disorders (22)  ·  Mental Disorders (20)  ·  Neurodevelopmental Disorders (20)  ·  Speech Disorders (16)  ·  Brain Diseases (12)  ·  Central Nervous System Diseases (11)  ·  Behavior (7)  ·  Cardiovascular Diseases (7)  ·  Cerebrovascular Disorders (7)

Interventions

Animal Assisted Therapy (1)  ·  BPN14770 (1)  ·  Commerce (1)  ·  Fluoxetine (1)  ·  Lead (1)  ·  Methods (1)  ·  SET protein, human (1)  ·  Standard of Care (1)  ·  Therapeutics (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Umbilical Cord Clamping (1)  ·  Zinc Acetate (1)  ·  carbidopa, levodopa drug combination (1)  ·  ecopipam (1)  ·  pagoclone (1)

Sponsors

Barretos Cancer Hospital (1)  ·  Children's Hospitals and Clinics of Minnesota (1)  ·  Children's University Hospital Cologne, Germany (1)  ·  Climb Up Kids (1)  ·  Emalex Biosciences Inc. (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Governors State University (1)  ·  H. Branch Coslett (1)  ·  I.R.C.C.S. Fondazione Santa Lucia (1)  ·  Lamar University (1)  ·  Medical University of South Carolina (1)  ·  Michigan State University (1)  ·  MindFrame, Inc. (1)  ·  Montclair State University (1)

Countries

United States (28)  ·  Germany (2)  ·  Australia (1)  ·  Brazil (1)  ·  Hong Kong (1)  ·  India (1)  ·  Italy (1)  ·  Norway (1)  ·  Russia (1)

Top investigators

Abhishek Datta, Ph.D (1)  ·  Alessandro Martorana, MD, PhD (1)  ·  Alexander A Ostanin, MD, PhD (1)  ·  Alexandre Jacinto, MD (1)  ·  Ann Kaiser, PhD (1)  ·  Atul R Mahableshwarkar, MD, DFAPA (1)  ·  Bruce Crosson, PhD (1)  ·  Catherine H Balthazar, PhD (1)  ·  Cheryl M Scott, PhD (1)  ·  Connie Kasari, PhD (1)  ·  Devendra Mehta, MBBS MSC MRCP (1)  ·  Elaine R. Hitchcock, PhD (1)  ·  Elena R Chernykh, MD, PhD (1)  ·  Gayatri Devi, MD (1)

Results publications

PMID 20145986, PMID 23106988, PMID 25267381, PMID 26547399, PMID 29357099, PMID 29954605, PMID 30128538, PMID 32878377, PMID 33643204, PMID 33927413, PMID 40277885, PMID 40809903, PMID 42542632

NIH funding

R01DC007387 (1), R01DC007660 (1), R01DC015642 (1), R01DC016321 (1), R01DC016800 (1), R15DC009027 (1), R15DC019775 (1), R44NS092144 (1), U01DC011739 (1), U01DC017521 (1)